Hungary (HU)

Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity Score-Matched Cohort Analysis of the GEC-ESTRO Breast Cancer Working Group Database (2021) Hannoun-Levi JM, Gal J, Van Limbergen E, Chand ME, Schiappa R, Smanyko V, Kauer-Domer D, et al. Journal article EULAR definition of difficult-To-Treat rheumatoid arthritis (2021) Nagy G, Roodenrijs NM, Welsing PM, Kedves M, Hamar A, Van Der Goes MC, Kent A, et al. Journal article Physical Activity, Screen Time, and Sleep Duration of Children Aged 6-9 Years in 25 Countries: An Analysis within the WHO European Childhood Obesity Surveillance Initiative (COSI) 2015-2017 (2020) Whiting S, Buoncristiano M, Gelius P, Abu-Omar K, Pattison M, Hyska J, Duleva V, et al. Journal article Carrier-envelope offset stable, coherently combined ytterbium-doped fiber CPA delivering 1 kW of average power (2020) Shestaev E, Haedrich S, Walther N, Eidam T, Klenke A, Seres , Bengery Z, et al. Journal article Updated insight into the mutational and phenotypic spectrum of MED13L-related intellectual disability (2020) Asadollahi R, Boonsawat P, Popp B, Torti E, Bader I, Vitobello A, Moutton S, et al. Conference contribution Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial (2020) Atreya R, Peyrin-Biroulet L, Klymenko A, Augustyn M, Bakulin I, Slankamenac D, Miheller P, et al. Journal article Spin-controlled generation of indistinguishable and distinguishable photons from silicon vacancy centres in silicon carbide (2020) Morioka N, Babin C, Nagy R, Gediz I, Hesselmeier E, Liu D, Joliffe M, et al. Journal article Social media in cardiovascular medicine: A contemporary review (2020) Ladeiras-Lopes R, Baciu L, Grapsa J, Sohaib A, Vidal-Perez R, Bohm A, Silvola H, et al. Journal article, Review article Central charges of aperiodic holographic tensor-network models (2020) Jahn A, Zimboras Z, Eisert J Journal article Cobitolimod for Moderate-to-Severe Left-Sided Ulcerative Colitis (CONDUCT): A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial (2020) Atreya R, Peyrin-Biroulet L, Klymenko A, Augustyn M, Bakulin I, Slankamenac D, Miheller P, et al. Conference contribution